Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Irritable Bowel Syndrome, May 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 109 articles: HTML format

Single Articles

1. MOHAMED FA, Hassan MM, Aboulmagd YM, Attallah KA, et al
   Pathophysiology-driven use of natural products in irritable bowel syndrome: a review.
   Naunyn Schmiedebergs Arch Pharmacol. 2026 May 1. doi: 10.1007/s00210-026-05337.
   PubMed    
   Abstract available
   
   

2. GUO H, Jiao K, Zhang H, Li H, et al
   Gender differences in the efficacy and safety of Maren Runchang Pills in treating constipation-predominant irritable bowel syndromes: A gender-stratified analysis.
   Medicine (Baltimore). 2026;105:e48549.
   PubMed    
   Abstract available
   
   

3. LIU H, Liu S, Zhang Q, Zhang S, et al
   Long-term risk of irritable bowel syndrome associated with triglyceride-glucose related indices: a large-scale prospective cohort study.
   Ther Adv Gastroenterol. 2025;18:17562848251383796.
   PubMed    
   Abstract available
   
   

4. ABBER SR, Santucci NR, Burton-Murray H, Atkins M, et al
   Disorders of Gut-Brain Interaction in Eating Disorders: A Review of Management Approaches.
   Curr Psychiatry Rep. 2026;28:26.
   PubMed    
   
   
   

5. MARASCO G, Hod K, Colecchia L, Cremon C, et al
   Burden, features and factor associated with disorders of gut-brain axis in Italy: results from the Rome foundation global epidemiology study.
   Intern Emerg Med. 2026 Apr 30. doi: 10.1007/s11739-026-04350.
   PubMed    
   Abstract available
   
   

6. LIU X, Wang M, Niu W, Li P, et al
   Disrupted prefrontal-sensorimotor functional connectivity mediates the association between depression and symptom severity in patients with irritable bowel syndrome.
   Front Hum Neurosci. 2026;20:1817128.
   PubMed    
   Abstract available
   
   

7. LOVDAHL J, Tornblom H, Ringstrom G, Palsson OS, et al
   Online Group Hypnotherapy for Irritable Bowel Syndrome-a Pilot Study.
   Neurogastroenterol Motil. 2026;38:e70328.
   PubMed    
   Abstract available
   
   

8. GUO Y, Wang D, Chen M, Wei X, et al
   Impact of Electroacupuncture on the Expression Profile of the Anterior Cingulate Cortex in a Rat Model of Irritable Bowel Syndrome Based on Transcriptome Sequencing and Bioinformatics Analysis [Response to Letter].
   J Pain Res. 2026;19:615613.
   PubMed    
   
   
   

9. MATAR A, Busciglio I, Eckert D, Linden DR, et al
   AN OPEN-LABEL TRIAL OF EFFECTS OF VARENICLINE IN NON-CONSTIPATION IRRITABLE BOWEL SYNDROME AND PAIN.
   Clin Gastroenterol Hepatol. 2026 Apr 25:S1542-3565(26)00317.
   PubMed    
   
   
   

10. SARAGA A, Bocchino R, Gade A, Wang MJ, et al
    Sertraline-Associated Microscopic Colitis Flare in Pregnancy.
    ACG Case Rep J. 2026;13:e02104.
    PubMed    
    Abstract available
    
    

11. BOUVY C, Kapuczinski A, Ibrahimi S, Leon M, et al
    Spondyloarthritis Associated With Collagenous Colitis-Case Report and Literature Review.
    Clin Case Rep. 2026;14:e72580.
    PubMed    
    Abstract available
    
    

12. DAVARI TANHA F, Ebrahimi M, Salehi F, Faraji N, et al
    Outcomes of Laparoscopic Surgery of Deep Infiltrating Endometriosis: A Prospective Cohort Study in Yas Infertility Center, Tehran :
    Galen Med J. 2025;14:e3899.
    PubMed    
    Abstract available
    
    

13. ZHOU Z, Li Y, Tu Y, He M, et al
    Efficacy and safety of Guanylyl cyclase C agonists (linaclotide and plecanatide) in patients with irritable bowel syndrome with constipation: a systematic review and meta-analysis of randomized controlled trials.
    Front Pharmacol. 2026;17:1761301.
    PubMed    
    Abstract available
    
    

14. OMELUDIKE EK, Nwabueze CO, Ubah N, Okeke N, et al
    Glucagon-Like Peptide-1 Receptor Agonists for Bile Acid Diarrhea: Emerging Evidence and Clinical Implications.
    Cureus. 2026;18:e105789.
    PubMed    
    Abstract available
    
    

15. LEE SH, Kim YK
    Chronic Pain and Major Depression: Shared Psychological and Neurobiological Mechanism.
    Adv Exp Med Biol. 2026;1502:133-145.
    PubMed    
    Abstract available
    
    

16. BHATTACHARYA K, Arabshomali A, Lin LY, Bazzazzadehgan S, et al
    Economic and humanistic burden of comorbid depression among individuals with irritable bowel syndrome in the non-institutionalized US adult population.
    J Affect Disord. 2026 Apr 24:121854. doi: 10.1016/j.jad.2026.121854.
    PubMed    
    Abstract available
    
    

17. LI H, Hasan MB, Zivarifar H, Hassankiadeh RF, et al
    Associations Between Irritable Bowel Syndrome, Depression, Anxiety, and Suicidal Ideation: a Partial Least Squares Path Analysis.
    Psychiatr Q. 2026 Apr 25. doi: 10.1007/s11126-026-10288.
    PubMed    
    
    
    

18. HUANG ST, Ji NN, Wang Y, Huang L, et al
    Environmental enrichment reverses ELS-induced visceral pain and depression through a prefrontal-limbic circuit involving CB1Rs.
    Commun Biol. 2026 Apr 24. doi: 10.1038/s42003-026-10105.
    PubMed    
    Abstract available
    
    

19. ALAM MJ, Wang K, Zhao T, Li F, et al
    Sex-specific effects of chronic electrical acustimulation and sacral nerve stimulation in a rodent model of irritable bowel syndrome.
    J Pain. 2026;44:106298.
    PubMed    
    Abstract available
    
    

20. WANG X, Gang W, Wang X, Zhou H, et al
    Acupuncture for irritable bowel syndrome comorbid with anxiety and depression: study protocol for a placebo run-in, randomized clinical trial.
    Front Psychiatry. 2026;17:1782020.
    PubMed    
    Abstract available
    
    

21. DAVIS CN, Toikumo S, Hatoum AS, Khan Y, et al
    Multivariate, Multi-Omic Analysis in 799,429 Individuals Identifies 134 Loci Associated with Somatoform Traits.
    Complex Psychiatry. 2026;12.
    PubMed    
    Abstract available
    
    

22. HABIBYAN YB, Sharkey KA, Nasser Y
    PROTEASES AND ABDOMINAL PAIN - OLD DOG, NEW (MICROBIAL) TRICKS.
    Cell Mol Gastroenterol Hepatol. 2026 May 5:101803.
    PubMed    
    
    
    

23. MENGEL EA, Overbeck G
    Management of children with irritable bowel syndrome in general practice - a systematic review.
    Dan Med J. 2026;73:A08250661.
    PubMed    
    Abstract available
    
    

24. CHENG Y, Zhang L, Zhang M, Yu J, et al
    Advances in research on the effects of bile acids and their receptors on intestinal function.
    Front Nutr. 2026;13:1821418.
    PubMed    
    Abstract available
    
    

25. THUEN C, Kenter RMF, Assmus J, Steinsvik EK, et al
    Internet-delivered cognitive behavioral therapy and FODMAP diet for adults with irritable bowel syndrome: A four-arm randomized controlled trial.
    Internet Interv. 2026;44:100949.
    PubMed    
    Abstract available
    
    

26. LINARES M, Grimaldi C, Palma N, Vintimilla B, et al
    Knowledge Does Not Translate Into Diagnostic Restraint: Application of Rome-Based IBS Diagnosis Among Medical Students in Latin America.
    Neurogastroenterol Motil. 2026;38:e70335.
    PubMed    
    Abstract available
    
    

27. ALI NT, Mehdi MAH, Abdullah RS, Gubran ANM, et al
    Systemic inflammation and malaria co-infection in irritable bowel syndrome: a cross-sectional study of 142 Yemeni patients.
    BMJ Open. 2026;16:e116392.
    PubMed    
    Abstract available
    
    

28. AJABNOOR SM, Tashkandi L
    Application of a food trigger score to identify common dietary triggers among Saudi adults with irritable bowel syndrome.
    Saudi J Gastroenterol. 2026 May 4. doi: 10.4103.
    PubMed    
    Abstract available
    
    

29. LI S, Chen JDZ
    Sacral Nerve Stimulation Ameliorates Visceral Hypersensitivity Following 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis in Rats by Suppressing Inflammation and Reducing Colonic Epithelial Permeability.
    Neuromodulation. 2026 Apr 13:S1094-7159(26)00080.
    PubMed    
    Abstract available
    
    

30. MARASCO G, Hod K, Colecchia L, Sperber AD, et al
    Comparative Study on Burden, Features and Determinants of Disorders of Gut-Brain Interaction Between Southern Europe and the Rest of Continent: Results From the Rome Foundation Global Epidemiology Study.
    United European Gastroenterol J. 2026;14:e70226.
    PubMed    
    Abstract available
    
    

31. ALBERT E, Mikhael-Moussa H, Wuestenberghs F, Leroi AM, et al
    Insomnia, A Comorbidity to Take Into Account in the Global Management of Patients With Irritable Bowel Syndrome?
    Neurogastroenterol Motil. 2026;38:e70336.
    PubMed    
    Abstract available
    
    

32. HADLANDSMYTH K, Lund BC
    Central nervous system-active medication polypharmacy among rural and urban veterans with fibromyalgia, migraine, or irritable bowel syndrome.
    Am J Health Syst Pharm. 2026 May 5:zxag136. doi: 10.1093.
    PubMed    
    Abstract available
    
    

33. NOZU T, Miyagishi S, Ishioh M, Takakusaki K, et al
    Repurposing Cimetidine as a Therapeutic Candidate for Irritable Bowel Syndrome in a Rat Model.
    Fundam Clin Pharmacol. 2026;40:e70091.
    PubMed    
    Abstract available
    
    

34. AKIF A, Munami JW, Das R, Shawon NJ, et al
    Dietary Polyphenols in Non-Communicable Chronic Diseases: Neuro-Enteric Mechanisms, Multi-Omics Biomarkers and Translational Opportunities.
    Food Sci Nutr. 2026;14:e71856.
    PubMed    
    Abstract available
    
    

35. KRISHNAN AA, Dinning PG, Holland MA
    A Biophysical Model of Human Colonic Motor Pattern Generation in Health and Disease.
    bioRxiv [Preprint]. 2026 Apr 20:2026.04.15.718795.
    PubMed    
    Abstract available
    
    

36. NGUYEN QH, Lam HT, Trinh TTT, Vo TD, et al
    Clinical Features and Symptom Burden in Vietnamese Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Single-Center Cross-Sectional Study Using IBS-SSS and IBS-QoL Scores.
    J Clin Med. 2026;15:2910.
    PubMed    
    Abstract available
    
    

37. HOGSTROM S, Duberg A, Philipson A, L Fagerberg U, et al
    A Dance and Yoga Intervention for Girls with Functional Abdominal Pain: Effects on Pain Frequency, Depressive Symptoms, Quality of Life, School Absenteeism, and Somatic Symptoms: A Randomized Controlled Trial.
    Children (Basel). 2026;13:542.
    PubMed    
    Abstract available
    
    

38. POP D, Aka IML, Pop RS, Bota V, et al
    Psychological Traits and Social Factors Associated with Irritable Bowel Syndrome in Children.
    Children (Basel). 2026;13:521.
    PubMed    
    Abstract available
    
    

39. PANARESE I, Spaggiari P, Albarello L, Arpa G, et al
    Pattern-based histologic approach in colitis without chronic architectural damage: GIPAD recommendations.
    Dig Liver Dis. 2026 May 2:S1590-8658(26)00703-6. doi: 10.1016/j.dld.2026.
    PubMed    
    Abstract available
    
    

40. HAJIVAND S, Sharifi M, Talebi A, Ghasemi M, et al
    beta-Sitosterol Restored Intestinal Barrier Integrity and Reduced Intestinal Hypermotility in Stress-Induced IBS: Comparison With Sertraline.
    J Biochem Mol Toxicol. 2026;40:e70789.
    PubMed    
    Abstract available
    
    

41. SINGH A, Bhattacharjee S, Singh Y, Kostova I, et al
    Parabiotics as Next-Generation Microbiome Therapeutics: Insights into Mechanisms, Evidence, and Therapeutic Potential.
    Curr Microbiol. 2026;83:345.
    PubMed    
    Abstract available
    
    

42. ZHANG J, Li H, Tan J, Wu J, et al
    Polygonatum sibiricum polysaccharide alleviates irritable bowel syndrome via multidimensional phenotypic improvement and sex-specific gut microbiota modulation in mice.
    J Ethnopharmacol. 2026 Apr 29:121789. doi: 10.1016/j.jep.2026.121789.
    PubMed    
    Abstract available
    
    

43. FU M, Chen Y, Gong L, Wang Z, et al
    Transcultural adaptation and validation of the Chinese version of the Visceral Sensitivity Index for patients with disorders of gut-brain interaction.
    Front Med (Lausanne). 2026;13:1810265.
    PubMed    
    Abstract available
    
    

44. HE X, Chen G, Feng L, Ji J, et al
    Down-Regulation of miR-149-5p Regulates Colon Mucosal Epithelial Cell Function by Targeting IGF2BP1 to Alleviate Irritable Bowel Syndrome.
    Neurogastroenterol Motil. 2026;38:e70331.
    PubMed    
    Abstract available
    
    

45. WANG F, Li X, Zhao P
    Serum FGL2 is correlated with the severity and psychological status of diarrhea-predominant irritable bowel syndrome.
    Front Med (Lausanne). 2026;13:1796532.
    PubMed    
    Abstract available
    
    

46. ZHENG M, Sun S, Lv B
    Impact of different stress paradigms on irritable bowel syndrome: Evidence from clinical and animal studies.
    J Int Med Res. 2026;54:3000605261447130.
    PubMed    
    Abstract available
    
    

47. BHATTACHARYA S, Devi D, Rungta S, Tripathi A, et al
    Exploring the Impact of Yoga on Autonomic Nervous System Function, Social Functioning, and Quality of Life in People with IBS.
    Int J Yoga Therap. 2026;36:Article 1.
    PubMed    
    Abstract available
    
    

48. MATHIAS RM, Plush SL, Edwards LE, Bogatic D, et al
    Intestinal Ultrasound Adds Diagnostic Value and Safety to a Dietitian-Led Clinic for Disorders of Gut-Brain Interaction.
    JGH Open. 2026;10:e70415.
    PubMed    
    Abstract available
    
    

49. ZHOU Y, Liu S, Zhang Q, Zhang S, et al
    Long-term risk of irritable bowel syndrome associated with social isolation and loneliness: a large-scale prospective cohort study with mediation analysis.
    Ther Adv Gastroenterol. 2026;19:17562848261446458.
    PubMed    
    Abstract available
    
    

50. PROSPERO L, Linsalata M, Riezzo G, Orlando A, et al
    Elevated Depressive Symptoms Shape Gut Barrier Integrity, LPS Translocation, and PUFA Composition in IBS-D: Evidence from a Low-FODMAP Dietary Intervention.
    Nutrients. 2026;18:1473.
    PubMed    
    Abstract available
    
    

51. OHLSSON B, Hellstrom PM, Bjorklund M
    Types and Outcomes of Dietary Interventions in IBS: A Scoping Review.
    Nutrients. 2026;18:1334.
    PubMed    
    Abstract available
    
    

52. MATHIAS RM, Bogatic D, Edwards L, Bibb L, et al
    Intestinal ultrasound reliably predicts fecal loading in patients with ulcerative colitis.
    J Crohns Colitis. 2026;20:jjag052.
    PubMed    
    Abstract available
    
    

53. BAI W, Qian Z, Yang Y, Huang G, et al
    Immune-related core gene identification in irritable bowel syndrome and prediction of regulatory traditional Chinese medicines.
    Medicine (Baltimore). 2026;105:e48430.
    PubMed    
    Abstract available
    
    

54. LABUS JS, Delgadillo DR, Cole S, Wang C, et al
    IBS stress reactivity phenotype is associated with blood transcriptome profiles and microstructural and functional brain changes.
    Neurobiol Stress. 2026;42:100806.
    PubMed    
    Abstract available
    
    

55. BAE Y, Shin WS, Park JH, Jeon SR, et al
    Risk of Autonomic Dysfunction in Irritable Bowel Syndrome: A Nationwide Matched Cohort Study.
    Gastroenterol Hepatol. 2026 May 8:502775. doi: 10.1016/j.gastrohep.2026.502775.
    PubMed    
    Abstract available
    
    

56. WANG Y, Zhang G, Lin S, Zhuang X, et al
    Dietary index for gut microbiota (DI-GM) and irritable bowel syndrome: a case-control study.
    Sci Rep. 2026 May 9. doi: 10.1038/s41598-026-50647.
    PubMed    
    Abstract available
    
    

57. CHEN W, Wu J, Su K, Ye K, et al
    High Remission of Somatic Symptom Disorder in Irritable Bowel Syndrome Supports ICD-11 Exclusion of Comorbid BDD.
    Gen Hosp Psychiatry. 2026;100:284-285.
    PubMed    
    
    
    

58. BAE Y, Jang M, Bak KY, Park JH, et al
    Association between irritable bowel syndrome and Guillain-Barre syndrome-related immune-mediated peripheral neuropathies: A nationwide cohort study.
    J Neuroimmunol. 2026;418:578961.
    PubMed    
    Abstract available
    
    

59. SUN Q, Gao Y, Zheng J, Liao R, et al
    Akkermansia muciniphila drives viscero-visceral crosstalk via 5-HT(3a)R-mediated sensitization of dichotomizing gut-bladder neurons.
    Exp Mol Med. 2026 May 8. doi: 10.1038/s12276-026-01720.
    PubMed    
    Abstract available
    
    

60. HOD K, Marasco G, Colecchia L, Sperber AD, et al
    Distinct pain profiles across irritable bowel syndrome subtypes: results from the Rome Foundation Global Epidemiology Study.
    Intern Emerg Med. 2026 May 8. doi: 10.1007/s11739-026-04375.
    PubMed    
    Abstract available
    
    

61. ZHAO Z, Chen Y, Zeng H, Fang Y, et al
    Health-related quality of life instruments in pediatric disorders of gut-brain interaction: a COSMIN-based systematic review.
    J Patient Rep Outcomes. 2026 May 22. doi: 10.1186/s41687-026-01093.
    PubMed    
    Abstract available
    
    

62. GHOFLCHI S, Vatanparast RG, Jalili-Nik M, Kesharwani P, et al
    Emerging roles of combined curcumin and berberine in disease modulation: a comprehensive review of mechanisms and therapeutic relevance.
    Mol Biol Rep. 2026;53:809.
    PubMed    
    Abstract available
    
    

63. PEREZ-SOTO N, Fregoso-Sanchez A, Miguel-Gonzalez JJ, Everding-Rodriguez AG, et al
    Tricuspid Valve Regurgitation Manifesting in Gastrointestinal Symptoms.
    JACC Case Rep. 2026 May 22:108481. doi: 10.1016/j.jaccas.2026.108481.
    PubMed    
    Abstract available
    
    

64. MO L, Wu Y, Zhou Y, He Y, et al
    Bifidobacterium breve Promotes the Pathogenesis of IBS by Downregulating the Expression of Ferroptosis-Related Molecule ERBB1: A Mendelian Randomization Mediation Analysis.
    Hum Mutat. 2026;2026:6705631.
    PubMed    
    Abstract available
    
    

65. REJILI M, Mustafa AM, Al-Kuraishy HM, Hussein NR, et al
    Duloxetine as a gut-brain axis modulator in irritable bowel syndrome: neuroimmune, microbiota, and pharmacogenomic perspectives.
    Naunyn Schmiedebergs Arch Pharmacol. 2026.
    PubMed    
    Abstract available
    
    

66. KITSELAAR WM, Hartmann L, Evers AWM, Numans ME, et al
    Longitudinal association of mental-health problems with subsequent diagnosis of persistent somatic symptom disorders: A large-scale registry-based observational study in primary care.
    Gen Hosp Psychiatry. 2026;101:45-51.
    PubMed    
    Abstract available
    
    

67. XU X, Liu T, Wang F, He H, et al
    Efficacy of Internet-Based Self-Help Interventions for Irritable Bowel Syndrome: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    J Med Internet Res. 2026;28:e87216.
    PubMed    
    Abstract available
    
    

68. SAROGI GK, Agrawal A, Kumari M, Sharma S, et al
    Immunomodulatory Roles of Probiotics: From Intestinal Barrier Regulation to Clinical Applications.
    Curr Pharm Biotechnol. 2026 May 15. doi: 10.2174/0113892010455159260407152252.
    PubMed    
    Abstract available
    
    

69. YANG B, Xu Z, Liu X, Bai T, et al
    Brain-targeted Therapies for Irritable Bowel Syndrome: Mechanisms and Strategies.
    Curr Neuropharmacol. 2026 May 15. doi: 10.2174/011570159X461707260327112414.
    PubMed    
    Abstract available
    
    

70. CHANG HC, Chang YW, Su YJ, Wu MC, et al
    Carpal tunnel syndrome as risk factor for subsequent development of irritable bowel syndrome: a retrospective cohort study.
    Sci Rep. 2026 May 20. doi: 10.1038/s41598-026-53244.
    PubMed    
    Abstract available
    
    

71. RANASINGHE PD, Barazanji N, Bednarska O, Bergman Jungestrom M, et al
    High-resolution metagenomic characterization of gut microbiota composition and functional pathways in irritable bowel syndrome.
    Sci Rep. 2026;16:15742.
    PubMed    
    Abstract available
    
    

72. REZAZADEGAN M, Soheilipour M, Amani R
    Effects of zinc and probiotic co-supplementation on inflammation, gastrointestinal symptoms, quality of life, and mood in irritable bowel syndrome patients.
    Sci Rep. 2026 May 20. doi: 10.1038/s41598-026-52347.
    PubMed    
    Abstract available
    
    

73. PETERS L, Matysiak A, Hubener S, Lohse AW, et al
    Response to the letter "High remission of somatic symptom disorder in irritable bowel syndrome supports ICD-11 exclusion of comorbid BDD".
    Gen Hosp Psychiatry. 2026;100:319-320.
    PubMed    
    
    
    

74. YANG X, Shui X
    Characteristics and clinical applicability of four dietary interventions for irritable bowel syndrome: A systematic review and meta-analysis.
    Clin Nutr. 2026;62:106680.
    PubMed    
    Abstract available
    
    

75. LIU Z, Xu Q, Wu X, Jin Z, et al
    Clinical characteristics and nutritional profiles of children with different irritable bowel syndrome subtypes: a retrospective hospital-based study.
    Transl Pediatr. 2026;15:114.
    PubMed    
    Abstract available
    
    

76. ZHOU M, He Y, Zhang L, Xia J, et al
    Gui-Shao San Umbilical Moxibustion for Diarrhea-Predominant Irritable Bowel Syndrome With Liver Depression and Spleen Deficiency Pattern: A Randomized Controlled Trial.
    Gastroenterol Res Pract. 2026;2026:1832176.
    PubMed    
    Abstract available
    
    

77. ALZOUBI MN, Aldhliki AB, Salameh HE, Al-Raymoony S, et al
    Prevalence of irritable bowel syndrome and its association with lifestyle factors among medical students in Jordan: a cross-sectional survey.
    Sci Rep. 2026 May 19. doi: 10.1038/s41598-026-52741.
    PubMed    
    Abstract available
    
    

78. QIU WJ, Chen Y, Ye SY, Chen L, et al
    Critical Role of Calcitonin Gene-related Peptide (CGRP) in the Microbiome-gut-brain Axis.
    Curr Protein Pept Sci. 2026 May 12. doi: 10.2174/0113892037454118260504132328.
    PubMed    
    Abstract available
    
    

79. JIANG Y, Zhang Z, Ding Y, Xu S, et al
    Causal effect of urinary sodium-to-creatinine ratio on gastrointestinal diseases: A two-sample Mendelian randomization study.
    Medicine (Baltimore). 2026;105:e48692.
    PubMed    
    Abstract available
    
    

80. MORASSE-BEGIS M, Trottier-Duclos F, Ngo TL
    [What do we know about compassion focused therapy for anxiety and depressive symptoms: A scoping review].
    Encephale. 2026 May 18:S0013-7006(26)00080-1. doi: 10.1016/j.encep.2026.
    PubMed    
    Abstract available
    
    

81. YUNUSOVA A, Levinthal DJ, Lam P, Brown KW, et al
    Beyond Chronic Stress: Daily Stress Is Associated with Symptoms in Irritable Bowel Syndrome.
    Clin Gastroenterol Hepatol. 2026 May 17:S1542-3565(26)00359.
    PubMed    
    Abstract available
    
    

82. NISTICO V, Demartini B, Geroin C, Marcuzzo E, et al
    Pain in Functional Motor Disorders: Clinical Correlates From the Italian Registry.
    Eur J Neurol. 2026;33:e70634.
    PubMed    
    Abstract available
    
    

83. LU D, Cunanan K, Cragun J, Vuong L, et al
    Phenotypes of Chronic Overlapping Pain Multimorbidity in Rheumatology: A Population-Based Claims Study.
    Arthritis Care Res (Hoboken). 2026 May 18. doi: 10.1002/acr.80090.
    PubMed    
    Abstract available
    
    

84. LEE HJ, Nguyen ADN, Jeong JH, Lee JY, et al
    The Etiologies and Characteristics of Chronic Abdominal Pain in Children and Adolescents in Korea.
    Pediatr Gastroenterol Hepatol Nutr. 2026;29:263-272.
    PubMed    
    Abstract available
    
    

85. KHASANOV R, Boettcher M, Wessel LM, Schafer KH, et al
    All roads lead to NF-kappaB: the NF-kappaB pathway as a major target for intestinal inflammatory disorders.
    Front Immunol. 2026;17:1816653.
    PubMed    
    Abstract available
    
    

86. POLTIYELOVA E, Zhang E, Pais J, Cohen C, et al
    Disaccharidase testing and clinical outcomes: a retrospective study.
    Proc (Bayl Univ Med Cent). 2026;39:401-404.
    PubMed    
    Abstract available
    
    

87. MA X, Zhu Y, Ma Y, Ma H, et al
    Activation likelihood estimation of convergent resting-state brain alterations in diarrhea-predominant IBS: a systematic review and meta-analysis.
    Quant Imaging Med Surg. 2026;16:383.
    PubMed    
    Abstract available
    
    

88. AHMAD HRM, Rawashdeh Z, Rawshdeh A, Kawafha YA, et al
    Helicobacter pylori Infection and Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis With a Narrative Review of the Evidence for Inflammatory Bowel Disease.
    Cureus. 2026;18:e107022.
    PubMed    
    Abstract available
    
    

89. DONICKE J, Cooper R, Soehner AM, Jalbrzikowski M, et al
    Risk Factors Associated with Longitudinal Trajectories of Mania Symptoms in Youth.
    medRxiv [Preprint]. 2026 May 10:2025.09.03.25334998.
    PubMed    
    Abstract available
    
    

90. YAO M, Zhang X, Lei F, Yan T, et al
    Association between social isolation, loneliness and the incidence of irritable bowel syndrome: a prospective cohort study in the UK Biobank.
    Ann Gen Psychiatry. 2026 May 16. doi: 10.1186/s12991-026-00649.
    PubMed    
    Abstract available
    
    

91. CAI L, Chen P, Mou W, Zhang L, et al
    Phenethylamine modulates intestinal inflammation and barrier integrity in diarrhea-predominant irritable bowel syndrome through the TAAR1-PKC signaling pathway.
    Tissue Cell. 2026;102:103603.
    PubMed    
    Abstract available
    
    

92. CRISTOFORI F, Celano G, Dargenio VN, Apa CA, et al
    Clinical trial: Efficacy of a Low FODMAP Diet in Paediatric Irritable Bowel Syndrome-A Randomised Crossover Trial With Exploratory Metabolomic Analysis.
    Aliment Pharmacol Ther. 2026 May 13. doi: 10.1111/apt.70718.
    PubMed    
    Abstract available
    
    

93. LOESCH J, Kim S, Simons M, Hamza E, et al
    Associations between Physical Activity and Irritable Bowel Syndrome in the All of Us Research Program.
    Am J Gastroenterol. 2026 Apr 27. doi: 10.14309/ajg.0000000000004037.
    PubMed    
    Abstract available
    
    

94. LEMBO AJ, Chey WD, Harris LA, Frazier R, et al
    Correction to: Abdominal Symptom Improvement During Clinical Trials of Tenapanor in Patients With Irritable Bowel Syndrome With Constipation: A Post Hoc Analysis.
    Am J Gastroenterol. 2026 May 4. doi: 10.14309/ajg.0000000000004025.
    PubMed    
    
    
    

95. QIN Z, Shi L, Zhang K, Pan M, et al
    Association of frail status with incident digestive diseases: A large prospective cohort study.
    Dig Dis. 2026 May 7:1-20. doi: 10.1159/000552186.
    PubMed    
    Abstract available
    
    

96. SAYUK GS, Brenner DM, Carbone F, Knowles SR, et al
    Design of Treatment Trials for Disorders of Gut-Brain Interaction.
    Gastroenterology. 2026;170:1388-1407.
    PubMed    
    Abstract available
    
    

97. CAMILLERI M, Sarnelli G, Andresen V, Greenwood-Van Meerveld B, et al
    Pharmacological, Pharmacokinetic, and Pharmacogenomic Aspects of Disorders of Gut-Brain Interaction.
    Gastroenterology. 2026;170:1152-1170.
    PubMed    
    Abstract available
    
    

98. DROSSMAN DA, Chang L, Tack J
    Disorders of Gut-Brain Interaction and the Rome V Process.
    Gastroenterology. 2026;170:1083-1098.
    PubMed    
    Abstract available
    
    

99. MA C, Ford AC, Hashash JG, Barbara G, et al
    Recommendations for the Evaluation and Management of Inflammatory Bowel Disease with Irritable Bowel Syndrome-Like Symptoms: A Joint Rome Foundation and International Organization for the Study of IBD (IOIBD) Consensus.
    Gastroenterology. 2026 Apr 29:S0016-5085(26)06758.
    PubMed    
    Abstract available
    
    

100. AUMPAN N, Watanabe J, Yuan Y, Kanno T, et al
     Fecal microbiota transplantation for symptom improvement in patients with irritable bowel syndrome: systematic review and meta-analysis of randomized controlled trials.
     Gastroenterology. 2026 May 19:S0016-5085(26)06874.
     PubMed    
     Abstract available
     
     

101. JIMENEZ-VARGAS NN, Sokrat B, Gilmor DA, Fialho MFP, et al
     Endosomal signalling of protease-activated receptor-2 amplifies histamine-induced pain of irritable bowel syndrome.
     Gut. 2026 May 19:gutjnl-2025-337991. doi: 10.1136/gutjnl-2025-337991.
     PubMed    
     Abstract available
     
     

102. GOYAL O, Aggarwal A, Goyal MK, Mehta V, et al
     Prevalence, clinical significance and predictors of small intestinal bacterial overgrowth and elevated fecal calprotectin in refractory irritable bowel syndrome: Insights from a prospective cross-sectional study.
     Indian J Gastroenterol. 2026 Apr 29. doi: 10.1007/s12664-026-01999.
     PubMed    
     Abstract available
     
     

103. SOLAK KHAN GN, Ilgen Uslu F
     Functional gastrointestinal disorders in adults with epilepsy: associations with psychological symptoms, chronotype, and seizure burden.
     Ir J Med Sci. 2026 May 6. doi: 10.1007/s11845-026-04396.
     PubMed    
     Abstract available
     
     

104. SHIBLI F, Dekel R, Yishai R, Lysy J, et al
     The Management of Irritable Bowel Syndrome: A Position Paper of the Neurogastroenterology and Motility Section of the Israeli Gastroenterology Association.
     J Clin Gastroenterol. 2026 May 1. doi: 10.1097/MCG.0000000000002388.
     PubMed    
     Abstract available
     
     

105. REN Z, Zhu H
     Comment on "Probiotics for Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis With Trial Sequential Analysis".
     J Gastroenterol Hepatol. 2026 May 14. doi: 10.1111/jgh.70443.
     PubMed    
     
     
     

106. AYAD ME, Yu S, El Shennawy S, Al Mowafy EA, et al
     Efficacy and Safety of Postbiotics in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
     J Gastroenterol Hepatol. 2026 May 8. doi: 10.1111/jgh.70421.
     PubMed    
     Abstract available
     
     

107. SUN K, Peng J, Zhu Y
     Probiotic Blend of Lactobacillus acidophilus LA-5 and Bifidobacterium animalis ssp. Lactis BB-12 in Non-Constipated Irritable Bowel Syndrome: A Double-Blind Randomized Placebo-Controlled Trial.
     J Gastroenterol Hepatol. 2026 May 15. doi: 10.1111/jgh.70454.
     PubMed    
     
     
     

108. FRANCAVILLA R, Dargenio VN, Castellaneta S, Cristofori F, et al
     From evidence to advice: How uncertainty shapes probiotic guidance in pediatric irritable bowel syndrome.
     J Pediatr Gastroenterol Nutr. 2026 May 6. doi: 10.1002/jpn3.70453.
     PubMed    
     
     
     

109. ANUMOLU A, Hamal A, Petrovski R, Acker E, et al
     Resilience in the face of adversity: Adverse and benevolent childhood experiences in irritable bowel syndrome.
     J Psychosom Res. 2026;208:112847.
     PubMed    
     Abstract available